Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine

被引:3
|
作者
Guo, Sa [1 ]
Xing, Nan [1 ]
Du, Qinyun [1 ]
Luo, Bin [2 ]
Wang, Shaohui [3 ,4 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Sch Ethn Med, State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
[4] Chengdu Univ Tradit Chinese Med, Meishan Hosp, Meishan, Peoples R China
关键词
hepatocellular carcinoma; anoikis; prognostic signature; ceRNA; active compounds; BREAST-CANCER; CELL-CYCLE; RESISTANCE; PROLIFERATION; EXPRESSION; PREDICTION; APOPTOSIS; PATHWAY; ARREST;
D O I
10.3389/fphar.2023.1325992
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Hepatocellular carcinoma (HCC) is responsible for approximately 90% of liver malignancies and is the third most common cause of cancer-related mortality worldwide. However, the role of anoikis, a programmed cell death mechanism crucial for maintaining tissue equilibrium, is not yet fully understood in the context of HCC.Methods: Our study aimed to investigate the expression of 10 anoikis-related genes (ARGs) in HCC, including BIRC5, SFN, UBE2C, SPP1, E2F1, etc., and their significance in the disease.Results: Through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, we discovered that these ARGs are involved in important processes such as tissue homeostasis, ion transport, cell cycle regulation, and viral infection pathways. Furthermore, we found a significant correlation between the prognostic value of five ARGs and immune cell infiltrates. Analysis of clinical datasets revealed a strong association between BIRC5 expression and HCC pathological progression, including pathological stage, T stage, overall survival (OS), and race. By constructing a competing endogenous RNA (ceRNA) network and using molecular docking, we identified ten bioactive compounds from traditional Chinese medicine (TCM) that could potentially modulate BIRC5. Subsequent in vitro experiments confirmed the influence of platycodin D, one of the identified compounds, on key elements within the ceRNA network.Discussion: In conclusion, our study presents a novel framework for an anoikis-centered prognostic model and an immune-involved ceRNA network in HCC, revealing potential regulatory targets. These insights contribute to our understanding of HCC pathology and may lead to improved therapeutic interventions.
引用
收藏
页数:18
相关论文
共 50 条
  • [32] Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition
    Li, Jia-jia
    Liang, Qing
    Sun, Guang-chun
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (06): : 469 - 477
  • [33] Traditional Chinese medicine combined with hepatic arterial chemotherapy and embolization in treating primary hepatocellular carcinoma
    Yong-He He
    Ji-Liang Fang
    Chinese Journal of Integrated Traditional and Western Medicine, 1997, 3 (2): : 117 - 119
  • [34] Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition
    Jia-jia Li
    Qing Liang
    Guang-chun Sun
    JournalofIntegrativeMedicine, 2021, 19 (06) : 469 - 477
  • [35] The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
    Jia, Wentao
    Liang, Shufang
    Cheng, Binbin
    Ling, Changquan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Identification of a novel survival and immune microenvironment related ceRNA regulatory network for hepatocellular carcinoma based on circHECTD1
    Lan, Shuiqing
    Zhong, Guoqiang
    HELIYON, 2024, 10 (13)
  • [37] Effect of an lncRNA-associated ceRNA regulatory network in MVI-positive hepatocellular carcinoma on their sensitivity to sorafenib.
    Luo, Zhiwen
    Bi, Xinyu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology
    Yin, Xiaofeng
    Li, Jinchuan
    Hao, Zheng
    Ding, Rui
    Qiao, Yanan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [39] Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in hepatocellular carcinoma: bayesian network meta-analysis and pharmacological mechanisms study
    Chen, Li
    Zhu, Xiu-Ling
    Lin, Jie
    Li, Dong-Liang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE
    Luo, Haoxuan
    Chen, Yan
    Sun, Baoguo
    Xiang, Ting
    Zhang, Shijun
    AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2017, 14 (01) : 165 - 173